The Myeloma Academy is dedicated to supporting and educating healthcare professionals to ensure patients are diagnosed quicker, best practice is shared and patients receive the best possible treatment and care. Aided by advances in technology, the myeloma field, particularly in the last decade, has rapidly evolved both scientifically and medically. This means that the…
Recommendations on the prevention, identification and management of neutropenic sepsis in cancer patients.
The Lawton Instrumental Activities of Daily Living (IADL) scale assesses the more complex activities of daily living necessary for living in the community, such as shopping, cooking and managing finances. These skills are usually lost before other activities of daily living functions are, such as bathing, dressing and eating.
The Eastern Cooperative Oncology Group (ECOG) performance status is a scale used to assess how a patient’s disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.
The Brief Fatigue Inventory is a simple yet sensitive tool that allows the severity and impact of cancer-related fatigue to be assessed.
No publications this month related to supportive care in myeloma
Panobinostat Approved for Multiple Myeloma. [No authors listed. Cancer Discov. 2015 Mar 23. [Epub ahead of print]. American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma. Glavey SV et al. Expert Rev Hematol. 2015 Mar 24:1-3. [Epub ahead of print]. Recent advances in multiple myeloma. Kohgo Y et al. Int J Clin Oncol. 2015 Mar 20. [Epub ahead of print]. Patterns of total cost…
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation. Roy V et al. Blood Cancer J. 2015 Mar 20;5:e294. doi: 10.1038/bcj.2015.23. Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma. Mai EK et al. Leukemia. 2015 Mar 19. doi: 10.1038/leu.2015.80. [Epub…
Cytomegalovirus reactivation in patients with multiple myeloma. Hasegawa T et al. Eur J Haematol. 2015 Mar 21. doi: 10.1111/ejh.12551. [Epub ahead of print] Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma. Gonsalves WI et al. Blood Cancer J. 2015 Mar 20;5:e296. doi: 10.1038/bcj.2015.20. Multiple myeloma presenting with a maxillary lesion as the first sign. Ramaiah KK et…
